X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse AMAR REMEDIES with UNILEVER PLC. - UK - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs UNILEVER PLC. (UK) - Comparison Results

UNILEVER PLC. (UK)
   Change

Unilever is an Anglo–Dutch multinational consumer goods company. It is present in 11 categories broadly divided into home care, personal care, refreshments and foods. Personal care and foods are the large segments with sales shares of 35% and 28%, re... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AMAR REMEDIES   UNILEVER PLC.
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
UNILEVER PLC.
Dec-14
AMAR REMEDIES/
UNILEVER PLC.
5-Yr Chart
Click to enlarge
High Rs1642,818-   
Low Rs862,284-   
Sales per share (Unadj.) Rs261.62,376.4-  
Earnings per share (Unadj.) Rs17.4270.6-  
Cash flow per share (Unadj.) Rs22.3325.9-  
Dividends per share (Unadj.) Rs094.23-  
Dividend yield (eoy) %03.7 0.0%  
Book value per share (Unadj.) Rs100.7669.8-  
Shares outstanding (eoy) m26.161,714.73-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.51.1 44.5%   
Avg P/E ratio x7.29.4 76.2%  
P/CF ratio (eoy) x5.67.8 71.7%  
Price / Book Value ratio x1.23.8 32.6%  
Dividend payout %034.8 0.0%   
Avg Mkt Cap Rs m3,2704,373,970 0.1%   
No. of employees `000NA173.0 0.0%   
Total wages/salary Rs m163509,323 0.0%   
Avg. sales/employee Rs ThNM23,554.5-  
Avg. wages/employee Rs ThNM2,944.1-  
Avg. net profit/employee Rs ThNM2,681.9-  
INCOME DATA
Net Sales Rs m6,8444,074,921 0.2%  
Other income Rs m2113,629 0.2%   
Total revenues Rs m6,8654,088,550 0.2%   
Gross profit Rs m1,131795,449 0.1%  
Depreciation Rs m12894,815 0.1%   
Interest Rs m39842,065 0.9%   
Profit before tax Rs m626672,199 0.1%   
Minority Interest Rs m0-28,941 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m121179,281 0.1%   
Profit after tax Rs m455463,977 0.1%  
Gross profit margin %16.519.5 84.7%  
Effective tax rate %19.326.7 72.5%   
Net profit margin %6.611.4 58.4%  
BALANCE SHEET DATA
Current assets Rs m4,9041,038,753 0.5%   
Current liabilities Rs m3,5811,652,481 0.2%   
Net working cap to sales %19.3-15.1 -128.3%  
Current ratio x1.40.6 217.9%  
Inventory Days Days12431 395.6%  
Debtors Days Days10038 264.3%  
Net fixed assets Rs m1,689881,009 0.2%   
Share capital Rs m26240,719 0.6%   
"Free" reserves Rs m2,3580-   
Net worth Rs m2,6351,148,459 0.2%   
Long term debt Rs m507604,558 0.1%   
Total assets Rs m6,8623,932,320 0.2%  
Interest coverage x2.617.0 15.2%   
Debt to equity ratio x0.20.5 36.6%  
Sales to assets ratio x1.01.0 96.2%   
Return on assets %12.412.9 96.6%  
Return on equity %17.340.4 42.7%  
Return on capital %31.039.1 79.3%  
Exports to sales %4.00-   
Imports to sales %00-   
Net fx Rs m2710-   
CASH FLOW
From Operations Rs m-313466,333 -0.1%  
From Investments Rs m-489-28,688 1.7%  
From Financial Activity Rs m769-436,635 -0.2%  
Net Cashflow Rs m-331,010 -3.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for UNILEVER PLC. (UK) is Euro. All data has been converted at 84.13 Rs / EUR

Compare AMAR REMEDIES With: P&G (US)  HYPERMARCAS (Brazil)  

Compare AMAR REMEDIES With: BATA INDIA  JYOTHY LABS  HUL  COLGATE  GILLETTE INDIA  



Today's Market

Indian Indices End Volatile Day in Red; Energy Stocks Drag(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day in red.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

Laurus Labs Ltd (IPO)

Dec 6, 2016

Equitymaster analyses Initial Public Offering (IPO) of Laurus Labs, one of the leading supplier of APIs for ARVs and Hepatitis C.

More Views on News

Most Popular

You Can Buy Select Auto Stocks Now for Big Long-Term Returns(The 5 Minute Wrapup)

Oct 17, 2018

Irrespective of the earnings hiccups, these businesses be setting new profit records.

Here's What You Should Do In this Market...(Profit Hunter)

Oct 9, 2018

Sticking to a process and discipline is the only way to survive and thrive in the market downcycles.

IPO Market Feels the Heat of the Market Crash(Sector Info)

Oct 12, 2018

The sentiments in primary market have also deteriorated amid the stock market correction. Most listed IPOs of 2018 are trading below their issue price.

Even If IL&FS Group Brought This Correction, this is Right Time to Buy & Sit Tight!(Chart Of The Day)

Oct 12, 2018

Even if IL&FS is the culprit, it may turn out to be a hero if you buy right and sit tight.

A Portfolio Strategy That Could Help You Reduce Shocks Of The Equity Market(Outside View)

Oct 9, 2018

PersonalFN explains a portfolio strategy that could help you reduce the shocks of the Indian equity market.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES - RELAXO FOOTWEARS COMPARISON

COMPARE AMAR REMEDIES WITH

MARKET STATS